370 related articles for article (PubMed ID: 21191688)
41. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer.
Yoda Y; Takeshima H; Niwa T; Kim JG; Ando T; Kushima R; Sugiyama T; Katai H; Noshiro H; Ushijima T
Gastric Cancer; 2015 Jan; 18(1):65-76. PubMed ID: 24510342
[TBL] [Abstract][Full Text] [Related]
42. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
43. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
[TBL] [Abstract][Full Text] [Related]
44. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
Yasui W; Yokozaki H; Fujimoto J; Naka K; Kuniyasu H; Tahara E
J Gastroenterol; 2000; 35 Suppl 12():111-5. PubMed ID: 10779229
[TBL] [Abstract][Full Text] [Related]
45. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes.
Mohsenzadeh M; Sadeghi RN; Vahedi M; Kamani F; Hashemi M; Asadzadeh H; Zali MR
Cancer Biomark; 2017 Jul; 20(1):7-15. PubMed ID: 28759951
[TBL] [Abstract][Full Text] [Related]
46. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.
Tahara S; Tahara T; Horiguchi N; Kato T; Shinkai Y; Yamashita H; Yamada H; Kawamura T; Terada T; Okubo M; Nagasaka M; Nakagawa Y; Shibata T; Yamada S; Urano M; Tsukamoto T; Kurahashi H; Kuroda M; Ohmiya N
Int J Cancer; 2019 Jan; 144(1):80-88. PubMed ID: 29978464
[TBL] [Abstract][Full Text] [Related]
48. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.
Solcia E; Fiocca R; Luinetti O; Villani L; Padovan L; Calistri D; Ranzani GN; Chiaravalli A; Capella C
Am J Surg Pathol; 1996; 20 Suppl 1():S8-22. PubMed ID: 8694148
[TBL] [Abstract][Full Text] [Related]
49. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic alterations in gastric carcinogenesis.
Choi IS; Wu TT
Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
[TBL] [Abstract][Full Text] [Related]
53. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Zhang Y; Zhang XR; Park JL; Kim JH; Zhang L; Ma JL; Liu WD; Deng DJ; You WC; Kim YS; Pan KF
Oncotarget; 2016 Jun; 7(24):37132-37144. PubMed ID: 27206798
[TBL] [Abstract][Full Text] [Related]
55. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
[TBL] [Abstract][Full Text] [Related]
56. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.
Oue N; Sentani K; Sakamoto N; Uraoka N; Yasui W
Int J Clin Oncol; 2019 Jul; 24(7):771-778. PubMed ID: 30980196
[TBL] [Abstract][Full Text] [Related]
57. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.
Otani K; Li X; Arakawa T; Chan FK; Yu J
Expert Rev Mol Diagn; 2013 Jun; 13(5):445-55. PubMed ID: 23782252
[TBL] [Abstract][Full Text] [Related]
60. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
